FindTrial
Sign In

Prospective cohort study and sample banking for myelodysplastic syndromes

Prospective cohort study and sample banking for the identification of biomarkers in myelodysplastic syndromes

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0002102
Enrollment
600
Registered
2016-10-14
Start date
2015-05-07
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

The Catholic University of Korea, Seoul St. Mary's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? patient group: patients diagnosed with MDS/ AML-MRC (acute myeloid leukemia - myeloid related change) with aggrement of informed consent. ? control group: patient diagnosed with osteoarthritis on femur or tibia which need for surgical osteotomy, and agree on the informed consent.

Exclusion criteria

Exclusion criteria: In a consecutive screening, patients with suspected MDS.AML-MRC who are finally diagnosed with another disease.

Design outcomes

Primary

MeasureTime frame
Analyze the enrolled subjects of gender, age, and peripheral blood findings (white blood cell count, hemoglobin, platelet count, etc.), chromosomal changes, WHO diagnosis, prognostic risk groups (IPSS, IPSS-R, etc.), treatment and survival outcomes.—

Secondary

MeasureTime frame
To identify the possble biomarkers—

Countries

Korea, Republic of

Contacts

Public ContactYoung-Woo Jeon

The Catholic University of Korea, Seoul St. Mary's Hospital

native47@naver.com+82-2-2258-6039

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026